Genotype-Specific HPV mRNA Triage Improves CIN2+ Detection Efficiency Compared to Cytology: A Population-Based Study of HPV DNA-Positive Women
Pathogens · 2025
DOI: 10.3390/pathogens14080749 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pathogens, 2025. Verfasst von S Sørbye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, University Hospital of North Norway, 9006 Tromsø, Norway. Hauptthemen laut MEDLINE: Papillomavirus Infections, RNA, Messenger, Uterine Cervical Neoplasms, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Effective triage of women testing positive for high-risk HPV DNA is essential to reduce unnecessary colposcopies while preserving cancer prevention. Cytology, the current standard, has limited specificity and reproducibility. The genotype-specific 7-type HPV E6/E7 mRNA test (PreTect HPV-Proofer’7), targeting HPV types 16, 18, 31, 33, 45, 52, and 58, detects transcriptionally active infections and may enhance risk stratification.
Methods
Between 2019 and 2023, 34,721 women aged 25–69 underwent primary HPV DNA screening with the Cobas 4800 assay at the University Hospital of North Norway, within the national screening program. Of these, 1896 HPV DNA-positive women were triaged with liquid-based cytology with atypical squamous cells of undetermined significance or worse (≥ASC-US) and the 7-type HPV mRNA test. Histological outcomes were followed through October 2024. Diagnostic performance for CIN2+ was evaluated overall and by genotype.
Results
CIN2+ prevalence was 13.3%. The mRNA test reduced test positivity from 50.3% to 33.4% while maintaining comparable sensitivity (70.6% vs. 72.2%) and improving specificity (72.3% vs. 53.0%) and PPV (28.1% vs. 19.1%). Genotype-specific PPVs were highest for HPV16 mRNA (47.7%), followed by HPV33 (39.2%) and HPV31 (32.2%), all exceeding corresponding DNA-based estimates.
Conclusion
Genotype-specific HPV mRNA triage offers superior risk discrimination compared to cytology, supporting more targeted, efficient, and accessible cervical cancer screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathology, University Hospital of North Norway, 9006 Tromsø, Norway.
- PreTect AS, 3490 Klokkarstua, Norway.
- Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, 9006 Tromsø, Norway.
ORCID-Profile: S Sørbye
Zitieren
APA
Sørbye, S., Falang, B. M., Antonsen, M., & Mortensen, E. (2025). Genotype-Specific HPV mRNA Triage Improves CIN2+ Detection Efficiency Compared to Cytology: A Population-Based Study of HPV DNA-Positive Women. Pathogens. https://doi.org/10.3390/pathogens14080749
Vancouver
Sørbye S, Falang BM, Antonsen M, Mortensen E. Genotype-Specific HPV mRNA Triage Improves CIN2+ Detection Efficiency Compared to Cytology: A Population-Based Study of HPV DNA-Positive Women. Pathogens. 2025. doi:10.3390/pathogens14080749
BibTeX
@article{Srbye2025,
author = {Sørbye, S and Falang, B M and Antonsen, M and Mortensen, E},
title = {Genotype-Specific HPV mRNA Triage Improves CIN2+ Detection Efficiency Compared to Cytology: A Population-Based Study of HPV DNA-Positive Women},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14080749}
}
EUVIMED